Molecular Binding Pairs in Drug Discovery and Design: A Comprehensive List

Here's a comprehensive list of molecular binding pairs commonly used in drug discovery and design:

1. Enzyme-substrate binding: Examples include the binding of an enzyme to its substrate, such as the binding of acetylcholinesterase to acetylcholine in the treatment of Alzheimer's disease.

2. Ligand-receptor binding: This involves the binding of a ligand molecule to a specific receptor, such as the binding of serotonin to serotonin receptors in the treatment of depression.

3. Protein-protein interaction: In drug design, targeting specific protein-protein interactions can be important. For example, the binding of tumor necrosis factor-alpha (TNF-α) to its receptor is targeted in the treatment of autoimmune diseases like rheumatoid arthritis.

4. Ion channel-drug interaction: Many drugs act by binding to specific ion channels, such as the binding of calcium channel blockers to calcium channels to treat hypertension.

5. DNA-drug interaction: Certain drugs bind to DNA, either by intercalation between base pairs or by covalent binding, to inhibit DNA replication or transcription. Examples include anticancer drugs like cisplatin and doxorubicin.

6. Antibody-antigen binding: In immunotherapy, antibodies can be designed to specifically bind to antigens on cancer cells or pathogens, leading to their destruction.

7. Covalent bond formation: Some drugs form covalent bonds with their target molecules, irreversibly inhibiting their activity. For instance, aspirin irreversibly acetylates cyclooxygenase enzymes, reducing inflammation and pain.

8. Metal coordination: Certain drugs contain metal ions that coordinate with specific proteins or enzymes, modulating their activity. Examples include metalloprotein inhibitors used in cancer treatment.

These are just a few examples of molecular binding pairs used in drug discovery and design. The specific pairs depend on the target disease or condition being treated and the mechanism of action of the drug.